盆腔磁共振仅计划在外照射放疗中临床实施的系统综述
研究分为MR采集与合成CT验证、MR畸变量化与体模开发、MR-only工作流程中患者治疗定位的临床验证以及MR-only调试流程四类。关键结论包括MR-only计划已在前列腺癌治疗中临床实施,但推广至所有盆腔部位仍需大量工作,MR扫描畸变已不再是障碍但需适当管理,患者定位验证有前景但证据有限,调试流程已有报告但需国家机构规范化。
要点
- MR-only计划已在前列腺癌放疗中临床实施
- 推广至所有盆腔部位仍需大量工作
- MR畸变已非障碍但需适当管理
核心结论
- MR-only计划已在前列腺癌治疗中临床实施
- 将MR-only计划推广至所有盆腔部位仍需大量工作
- MR扫描畸变已不再是MR-only计划的障碍,但必须适当管理
- 基于MR-only的患者定位验证有前景,但文献证据有限,需进一步研究
- 已有多种MR-only调试流程报告,可帮助中心开展本地调试,但需国家机构正式纳入指南
主要发现
- MR-only计划已在前列腺癌治疗中临床实施。
- 将MR-only计划推广至所有盆腔部位仍需大量工作。
- MR扫描畸变已不再是MR-only计划的障碍,但必须适当管理。
- 基于MR-only的患者定位验证有前景,但文献证据有限,需进一步研究。
临床怎么用
- 在前列腺癌放疗中可考虑实施MR-only计划。
- 实施MR-only计划时需适当管理MR扫描畸变。
- 可参考已报告的MR-only调试流程开展本地调试,但需等待国家机构正式指南。
局限性
- 基于MR-only的患者定位验证文献证据有限。
- MR-only调试流程需国家机构正式纳入指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The use of magnetic resonance (MR) imaging scans alone for radiation therapy treatment planning (MR-only planning) has been highlighted as one method of improving patient outcomes. Recent technologic advances have meant that introducing MR-only planning to the clinic is becoming a reality, with several specialist radiation therapy clinics using this technique for treatment. As such, substantial efforts are being made to introduce this technique into wide-spread clinical implementation. A systematic review of publications investigating the clinical implementation of pelvic MR-only radiation therapy treatment planning was undertaken following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The Medline, Embase, Scopus, Science Direct, Cumulative Index to Nursing and Allied Health Literature, and Web of Science databases were searched (timespan: all years to January 2, 2019). Twenty-six articles met the inclusion criteria. The studies were grouped into the following categories: (1) MR acquisition and synthetic computed tomography generation verification, (2) MR distortion quantification and phantom development, (3) clinical validation of patient treatment positioning in an MR-only workflow, and (4) MR-only commissioning processes. Key conclusions from this review are (1) MR-only planning has been implemented clinically for prostate cancer treatments; (2) a substantial amount of work remains to translate MR-only planning into widespread clinical implementation for all pelvic sites; (3) MR scanner distortions are no longer a barrier to MR-only planning, but they must be managed appropriately; (4) MR-only-based patient positioning verification shows promise, but limited evidence is reported in the literature and further investigation is required; and (5) a number of MR-only commissioning processes have been reported, which can aid centers as they undertake local commissioning; however, this needs to be formalized in guidance from national bodies.
引用
- Bird D, Henry AM, Sebag-Montefiore D, et al. A Systematic Review of the Clinical Implementation of Pelvic Magnetic Resonance Imaging-Only Planning for External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019. PMID: 31271829. doi:10.1016/j.ijrobp.2019.06.2530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。